Drug Industry Lawyers, Experts Helped Shape US Drug Price Cuts

A list of pharmaceutical representatives at the table when the Biden administration negotiated Medicare drug prices reveals how manufacturers defended their medicines before agreeing to lower drug prices.

Justifications from the Centers for Medicare & Medicaid Services released ahead of a March deadline describing how the agency determined the prices of some of the most expensive and widely used drugs covered under Medicare unveiled who was at the front lines in a negotiation process largely held behind closed doors.

Meeting minutes disclosed that government and manufacturer attendees ranged from general counsel and policy heads to experts on global pricing ...